Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genes show the way to better treatment of hepatitis A

23.12.2014

One of the most common causes of hepatitis A (formerly known as infectious hepatitis) is a hepatitis C virus infection in the liver. The disease can be treated medically, but not all patients are cured by the treatment currently available. New research shows that the response to medical treatment depends on genetic factors.

Our best defence against viral infections is the immune system. However, humans are endowed differently in terms of our immune defence. Recent research has shown how our genetic make-up heavily influences our ability to combat viral infections. Surprisingly, it now turns out that some of the genes that are good for the immune system can at the same time impede medical treatment.

Hepatitis C virus (HCV) infection causes chronic inflammation of the liver, which is slowly broken down and in some cases the disease can progress to liver cancer. It is possible to treat the disease with antiviral medicine, but patients react differently to the treatment and not all of them recover.

An international research group led by scientists at Aarhus University, Denmark, has now found out why some patients respond to the treatment, while others do not. The result of the treatment is determined to a very great extent by the individual patient's genetic heritage (genome). To the great surprise of the researchers, it turns out that variations in our genes for the interferon lambda 4 protein (IFNL4) determine whether we respond well or poorly to treatment.

"Our research shows that genetic mutations that reduce the activity of the interferon lambda 4 protein provide patients with a considerably better chance of recovering from the infection. Or to put it another way, a functional interferon lambda 4 protein is harmful during an infection with HCV. This is paradoxical because IFNL4 is an essential part of our immune defence against viral infections, and should therefore have a positive effect," says Associate Professor Rune Hartmann, Department of Molecular Biology and Genetics, Aarhus University.

Paradox in the laboratory

IFNL4 is a member of the family of proteins called interferons (named after their ability to interfere with viruses), which are an essential part of our immune defence against viral infections. They work by activating a cellular programme that combats viral infections and thereby makes the cells resistant to the virus.

The research group's studies show that IFNL4 has a powerful antiviral activity in the laboratory, and behaves in every way like any other member of the interferon family. Even though IFNL4 is antiviral in the laboratory, the research also clearly shows that it has the opposite effect in patients. This is where the paradox arises. The researchers have a possible explanation of why this happens.

"Our hypothesis is that interferon lambda 4 confuses other parts of the immune system and that HCV is able to exploit this," says PhD student Ewa Terczynska-Dyla, who also took part in the research project.

Possibility of better treatment

The research results from Aarhus University indicate that it is possible to develop new treatments for hepatitis that match the individual patient's genome. This could be medicine specifically targeting IFNL4, but could also include modifying the normal treatment, depending on whether the patients have fully functional IFNL4 genes, or have a version with either reduced activity or no activity at all.

The latter group of patients is by far the biggest in Denmark, and they do not require anywhere near as long a period of treatment to recover. This is good for both the patients (because they avoid unnecessary treatment) and the public medical expenses (because HCV medicine is very expensive).

The researchers will now carry out further work to understand the fundamental mechanisms that make the interferon lambda genes so important for our ability to combat hepatitis caused by HCV.

The results will be published in the journal Nature Communications 23 December 2014.

For more information, please contact

Associate Professor Rune Hartmann
Department of Molecular Biology and Genetics
Aarhus University, Denmark
+45 2899 2578
rh@mbg.au.dk

PhD student Ewa Terczynska-Dyla
Department of Molecular Biology and Genetics
Aarhus University, Denmark
+45 8715 6638
ewat@mbg.au.dk

Rune Hartmann | EurekAlert!
Further information:
http://www.au.dk

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>